US-based private equity firm Coalesce Capital has acquired a majority stake in healthcare IT provider DAS Health Ventures for an undisclosed sum.
DAS Health supplies IT services, cybersecurity, revenue cycle management, Cloud hosting, practice management, and business solutions to healthcare organisations across North America.
Go deeper with GlobalData
The company’s offerings are designed to streamline workflows and enhance patient care.
Coalesce’s investment aims to support DAS Health’s growth through advancements in technology, talent recruitment and strategic acquisitions.
One of DAS Health’s existing investors, Sheridan Capital Partners, will maintain a minority ownership position while continuing to support the company’s expansion.
DAS Health president and CEO Michelle Jaeger said: “Their investment underscores our commitment to delivering innovative solutions that help healthcare organisations operate more efficiently and improve patient care.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData“With Sheridan’s continued support, we are well-positioned to broaden our reach and help even more providers achieve operational excellence and better outcomes.”
Coalesce Capital founder and managing partner Stephanie Geveda said: “As healthcare organisations face growing challenges in patient data management, regulatory compliance, and operational demands, DAS Health stands out as a trusted partner solving these critical pain points.
“We are excited to invest in DAS Health, whose proven track record for delivering reliable, mission-critical solutions has already improved care for over 15 million patients. We look forward to supporting their continued growth.”
DAS Health operates from its headquarters in Tampa, Florida, and has regional offices across 15 US states and Canada.
The company’s financial and legal advisors for the deal were Houlihan Lokey and McDermott Will & Emery respectively, while Lazard and Latham & Watkins advised Coalesce Capital.
Based in New York, Coalesce Capital invests in ‘human capital-driven and technology-enabled’ services companies across various industries.
The company currently has more than $1.4bn in regulatory assets under its management.
